HUAFON COVATION BIOMATERIALS JIANGSU CO., LTD.

Introduction

Huafon Covation Biomaterials Jiangsu Co., Ltd. (江苏华峰瑞讯生物材料有限公司) is a Chinese biomaterials company associated with Huafon Group and the Covation Biomaterials business. It operates within the plastics and advanced-materials sector, focusing on bio-based chemical building blocks, polymers, and related sustainable-material solutions for applications including textiles, footwear, coatings, personal care, and other consumer and industrial markets.

The company forms part of Huafon’s broader materials portfolio, which includes polyurethane, polyamide, spandex, adipic-acid derivatives, and other polymer-related products. Huafon Group, founded in 1991 and headquartered in Zhejiang, expanded its biomaterials activities through the acquisition of DuPont’s biomaterials business, which was subsequently developed under the Covation Biomaterials identity.

Covation Biomaterials’ technology platform is associated particularly with partially or fully bio-based materials such as Sorona, Susterra, and Zemea, as well as newer materials under development or commercialization, including bio-based polyether diol. Its strategic significance lies in connecting renewable carbon feedstocks with established polymer-processing and formulation technologies, allowing manufacturers to reduce reliance on fossil-based inputs while retaining required performance characteristics.

History and Development

Covation Biomaterials emerged from a biomaterials business originally developed within DuPont. The business introduced commercially established bio-based materials for applications extending from fibers and polymers to solvents, personal-care ingredients, and industrial formulations.

Several milestones shaped the company’s development:

1991: Huafon Group was established in China and subsequently developed a diversified chemicals and advanced-materials portfolio.
2022: Huafon acquired DuPont’s biomaterials business and launched Covation Biomaterials as an independent business platform.
2022 onward: The business continued commercial development of Sorona, Susterra, and Zemea while integrating biomaterials expertise with Huafon’s manufacturing and investment capabilities.
2026: Covation Biomaterials advanced plans for the commercialization of bio-based polyether diol, commonly referred to as bioPTMEG, while revising its ownership and supply arrangements for bio-based 1,3-propanediol.
2026: The company publicized the achievement of initial mass-production targets for Xatryx and presented a non-food bio-based application in footwear materials.

The company’s evolution reflects a wider transition in the plastics industry from isolated bio-based products toward integrated platforms combining renewable feedstocks, polymer synthesis, compounding, product design, and supply-chain certification.

Business Operations and Segments

Huafon Covation Biomaterials Jiangsu operates within a business structure centered on bio-based materials and their industrial applications. Its activities can be grouped into several areas:

Bio-based chemical intermediates: Renewable-carbon building blocks used in polymers, coatings, formulations, and specialty chemical products.
Bio-based polymers: Materials designed to substitute for, or reduce the fossil-derived content of, conventional synthetic polymers.
Performance additives and formulation ingredients: Plant-derived materials used in personal care, home care, pharmaceutical, food-flavor, coating, and industrial-fluid formulations.
Application development: Technical support for customers seeking to incorporate bio-based materials into fibers, footwear, coatings, inks, packaging, and consumer products.
Sustainability-oriented product development: Development of materials intended to reduce product carbon footprints, diversify feedstocks, or improve renewable-content credentials.

The company is linked to Huafon’s wider industrial ecosystem, which includes polymer manufacturing, polyurethane and polyamide production, spandex, microfiber, and other downstream materials. This relationship provides potential advantages in manufacturing expertise, customer access, procurement, and integration with established plastics-processing markets.

Products and Technologies

Sorona

Sorona is a partially bio-based polymer platform associated with textile and carpet applications. It is based on polymer chemistry incorporating bio-derived content and is used in fibers and other products where softness, resilience, durability, and design flexibility are required.

Typical processing routes for Sorona-related applications include:

Melt spinning into textile filaments or staple fibers.
Fiber texturing and blending with other synthetic or natural fibers.
Extrusion and downstream conversion into fabrics, carpets, apparel, and footwear components.
Use in products requiring recovery, resilience, dimensional stability, or aesthetic performance.

The environmental profile of a partially bio-based polymer depends on factors such as feedstock origin, manufacturing energy, polymer composition, transport, durability, and end-of-life treatment. Renewable content therefore represents one element of a product’s overall life-cycle assessment rather than a complete measure of environmental performance.

Susterra

Susterra is a plant-based chemical platform used as a building block in applications such as polyurethane systems, coatings, inks, footwear, and functional fluids. Its role is to replace some petroleum-derived components while contributing functional properties to finished formulations.

Depending on the grade and application, bio-based polyols and related intermediates may influence:

Flexibility and resilience in polyurethane products.
Solvent and formulation performance.
Coating and ink characteristics.
Low-temperature behavior and handling properties.
Renewable-carbon content and product-footprint calculations.

The material is generally used within established industrial formulation and processing systems rather than requiring an entirely new manufacturing infrastructure.

Zemea

Zemea is a plant-derived material used in personal care, home care, pharmaceutical, food-flavor, and related formulation markets. Its biodegradability and formulation compatibility support applications where manufacturers seek renewable-content or environmental attributes alongside established performance.

The product illustrates the company’s presence beyond conventional plastics. It occupies an intermediate position between polymer raw materials and specialty formulation ingredients, demonstrating how biomaterials companies can serve both plastics-related and non-plastics markets.

Bio-based polyether diol

Covation Biomaterials has also been preparing the commercialization of bio-based polyether diol, commonly identified as bioPTMEG. Polyether diols are important intermediates in polyurethane, elastomer, thermoplastic polyurethane, spandex, and related systems.

A bio-based polyether-diol platform could be incorporated into products requiring:

Elastic recovery.
Abrasion resistance.
Flexibility over a broad temperature range.
Soft-touch characteristics.
Compatibility with polyurethane and elastomer processing.

Commercial success depends on consistent molecular weight, hydroxyl functionality, color, purity, viscosity, storage stability, and compatibility with existing polymerization and compounding equipment.

Xatryx and emerging materials

Company-related announcements describe Xatryx as an emerging bio-based material platform and report initial mass-production milestones as well as footwear applications. Such products are part of a broader movement toward non-food renewable feedstocks, in which manufacturers seek to avoid direct competition with food supply chains and improve the traceability of renewable raw materials.

Applications and End Markets

The company’s materials address multiple end markets:

End market	Representative uses
Textiles and apparel	Fibers, fabrics, performance garments, outdoor clothing, and blends
Carpets and interior textiles	Durable and resilient carpet fibers and related textile products
Footwear	Insoles, midsoles, cushioning components, coatings, and bio-based shoe materials
Polyurethane and elastomers	Polyols, flexible materials, coatings, sealants, and elastomer systems
Coatings and inks	Renewable-content binders, solvents, and formulation ingredients
Personal care	Plant-derived ingredients for cosmetic and personal-care formulations
Home care	Functional formulation components and specialty ingredients
Pharmaceuticals and food-related formulations	Ingredients used in selected pharmaceutical, flavor, and food applications
Industrial fluids	Functional fluids and specialty chemical formulations

Textiles and footwear are particularly important because brands in these sectors increasingly seek materials that combine performance with measurable renewable content or reduced dependence on fossil-based feedstocks. At the same time, demand is influenced by price, supply reliability, processing compatibility, certifications, durability, and the credibility of environmental claims.

Global Presence and Market Position

Covation Biomaterials was established as an international biomaterials business following Huafon’s acquisition of the former DuPont biomaterials activities. The business has maintained a global orientation, serving multinational brands, chemical formulators, polymer processors, and manufacturers across several regions.

Its market position is defined less by a single commodity polymer than by a portfolio approach combining:

Bio-based monomers and intermediates.
Specialty polymer platforms.
Formulation ingredients.
Application engineering.
Sustainability-related technical support.

This positioning differentiates the company from conventional bulk petrochemical producers while placing it in competition with bio-based polymer developers, specialty chemical companies, renewable-feedstock suppliers, and established polymer manufacturers introducing lower-carbon product lines.

The company’s association with Huafon provides access to a large Chinese chemical-manufacturing base and to downstream markets in fibers, polyurethane, polyamide, and related materials. Its participation in CHINAPLAS activities also places it within the international plastics-machinery, processing, and materials network. The company has been identified as a government-recognized specialized and innovative enterprise in China.

Research and Development

Research and development activities focus on translating renewable feedstocks into materials that can meet the technical and economic requirements of existing manufacturing systems. Key areas include:

Development of renewable-carbon chemical intermediates.
Polymerization and formulation of bio-based monomers.
Compatibility with conventional extrusion, spinning, molding, coating, and compounding equipment.
Optimization of molecular weight, functionality, viscosity, purity, and thermal behavior.
Development of non-food feedstock routes.
Adaptation of materials for footwear, textiles, coatings, and specialty formulations.
Scaling from laboratory and pilot production to stable commercial manufacturing.

The technical challenge is not simply to increase renewable content. Bio-based materials must also provide reliable batch-to-batch performance, meet regulatory requirements, remain cost-competitive, and function within customers’ established processing windows.

Sustainability and Environmental Initiatives

The company’s sustainability strategy is centered on renewable raw materials and the reduction of fossil-derived content in selected products. Its portfolio includes materials described as plant-based, partially bio-based, biodegradable, or suitable for carbon-footprint reduction, depending on product and application.

Relevant sustainability dimensions include:

Use of renewable feedstocks.
Development of non-food bio-based raw materials.
Potential reduction in dependence on petroleum-derived intermediates.
Product-level carbon-footprint assessment.
Application of bio-based materials in durable consumer goods.
Development of chemical routes that can be integrated into existing manufacturing systems.

Environmental performance varies by product and supply chain. Important variables include agricultural practices, land use, feedstock processing, energy sources, transport, product durability, recycling infrastructure, and end-of-life treatment. Bio-based content does not automatically establish biodegradability or recyclability, and these attributes must be assessed separately.

The company’s sustainability activities also intersect with broader Huafon initiatives. In 2026, Huafon was reported to be working with Circ on a proposed textile-recycling facility designed to process blended textile waste and recover polyester and cellulosic components. Although textile recycling is distinct from bio-based polymer production, the project illustrates the wider circular-materials context in which Huafon’s biomaterials business operates.

Financial Performance and Economic Impact

Huafon Group is a large diversified chemical and materials enterprise with activities spanning polyurethane, polyamide, spandex, adipic-acid derivatives, and other products. Covation Biomaterials extends this portfolio into renewable-carbon materials and specialty biomaterials.

The economic contribution of the Jiangsu company and its associated business activities can be considered through several channels:

Manufacturing and technical employment in advanced materials.
Demand for renewable and specialty chemical feedstocks.
Supply of differentiated materials to textile, footwear, coatings, and consumer-goods manufacturers.
Support for customer product development and sustainability programs.
Expansion of higher-value chemical production beyond commodity polymers.
Integration of biomaterials with Huafon’s established manufacturing and distribution network.

The commercial outlook is influenced by raw-material costs, customer adoption, regulatory incentives, brand sustainability commitments, certification expenses, and the ability to achieve large-scale production with stable quality. Bio-based products often compete not only on material price but also on performance, traceability, environmental attributes, and customer access to certified supply chains.

Quality Management and Certifications

Quality management is central to the commercialization of bio-based materials because customers generally require performance consistency equivalent to that of conventional materials. Relevant controls may include:

Raw-material qualification and traceability.
Molecular and compositional analysis.
Batch consistency testing.
Thermal, mechanical, rheological, and application-specific evaluation.
Process validation during scale-up.
Regulatory and customer documentation.
Environmental-attribute verification where renewable content or biodegradability is claimed.

The company is identified in CHINAPLAS exhibitor information as a specialized and innovative enterprise recognized under China’s industrial policy framework. Specific product certifications and standards can differ by market and application, particularly where materials are used in textiles, cosmetics, food-related formulations, pharmaceuticals, or consumer products.

Innovations and Future Outlook

The company’s future development is likely to be shaped by five interconnected trends:

Expansion of bio-based polymer intermediates: Commercialization of materials such as bio-based polyether diol could extend renewable-content options into elastomers, polyurethane systems, and performance fibers.
Non-food feedstock development: Renewable materials based on non-food sources may help address concerns related to land use and food-versus-material competition.
Brand-driven material substitution: Apparel, footwear, and consumer-product brands continue to seek materials that support environmental targets without sacrificing performance.
Circularity and recycling: Bio-based production is increasingly being considered alongside mechanical recycling, chemical recycling, textile recovery, and design-for-recyclability initiatives.
Life-cycle transparency: Future competitiveness will depend increasingly on verified carbon accounting, chain-of-custody systems, product certifications, and clear separation of claims concerning renewable content, biodegradability, recyclability, and carbon reduction.

The principal challenges are scale, cost, feedstock security, technical consistency, regulatory compliance, and the need to demonstrate environmental benefits across complete life cycles. The company’s connection to Huafon’s established chemical-manufacturing capabilities may support scale-up, while its long-term position will depend on converting biomaterials innovation into dependable, commercially competitive products.

Summary

Huafon Covation Biomaterials Jiangsu Co., Ltd. is part of a biomaterials platform created through the integration of Covation Biomaterials with Huafon Group. Its activities span bio-based polymers, chemical intermediates, specialty formulation ingredients, and emerging renewable-carbon materials.

The company’s principal significance in the plastics industry lies in linking bio-based chemistry with established polymer-processing markets. Products associated with Sorona, Susterra, Zemea, bio-based polyether diol, and emerging platforms such as Xatryx address demand for renewable content, lower fossil dependence, and material innovation across textiles, footwear, polyurethane, coatings, personal care, and industrial formulations.

Its future development will depend on technical performance, production scale, feedstock sustainability, verified environmental data, and the ability to integrate bio-based materials into broader circular and low-carbon manufacturing systems.

References

•
CPS+ eMarketplace. (n.d.). HUAFON COVATION BIOMATERIALS JIANGSU CO., LTD.HUAFON COVATION BIOMATERIALS JIANGSU CO., LTD.. CPS+ eMarketplace. https://www.chinaplasonline.com/eMarketplace/ExhibitorInfo?CompId=1036756Link